LEANNE KOCEMBA: Open Payments
NPI 1922435684 · PRESCOTT, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,530 in 101 payments from 39 companies in 2025. Trend: 2023 $1,141 · 2024 $3,044 · 2025 $2,530
Food & beverage: $2,252Education: $278
| Company | Payments | Amount |
|---|---|---|
| Daiichi Sankyo Inc. | 7 | $185 |
| ABBVIE INC. | 6 | $170 |
| Incyte Corporation | 4 | $158 |
| PFIZER INC. | 9 | $157 |
| Novartis Pharmaceuticals Corporation | 7 | $150 |
| Merck Sharp & Dohme LLC | 5 | $123 |
| AstraZeneca Pharmaceuticals LP | 3 | $122 |
| Stemline Therapeutics Inc. | 4 | $116 |
| SEAGEN INC. | 1 | $100 |
| Genmab U.S., Inc. | 4 | $99 |
Products named: Enhertu, KEYTRUDA, Orserdu, OPDIVO, Epkinly, VENCLEXTA, LYNPARZA, VERZENIO.
Industry payments across AZ — which companies pay providers there.
